- Home
- QVCGA vs ANTX Comparison
QVCGA vs ANTX Comparison
Compare QVCGA & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- ANTX
- Stock Information
- Founded
- QVCGA 1991
- ANTX 2017
- Country
- QVCGA United States
- ANTX United States
- Employees
- QVCGA N/A
- ANTX N/A
- Industry
- QVCGA
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- ANTX Health Care
- Exchange
- QVCGA NYSE
- ANTX Nasdaq
- Market Cap
- QVCGA 26.1M
- ANTX 33.2M
- IPO Year
- QVCGA N/A
- ANTX 2022
- Fundamental
- Price
- QVCGA $2.66
- ANTX $1.05
- Analyst Decision
- QVCGA
- ANTX Buy
- Analyst Count
- QVCGA 0
- ANTX 2
- Target Price
- QVCGA N/A
- ANTX $2.00
- AVG Volume (30 Days)
- QVCGA 104.9K
- ANTX 257.5K
- Earning Date
- QVCGA 08-07-2025
- ANTX 08-12-2025
- Dividend Yield
- QVCGA N/A
- ANTX N/A
- EPS Growth
- QVCGA N/A
- ANTX N/A
- EPS
- QVCGA N/A
- ANTX N/A
- Revenue
- QVCGA $9,800,000,000.00
- ANTX N/A
- Revenue This Year
- QVCGA $2.89
- ANTX N/A
- Revenue Next Year
- QVCGA $0.45
- ANTX N/A
- P/E Ratio
- QVCGA N/A
- ANTX N/A
- Revenue Growth
- QVCGA N/A
- ANTX N/A
- 52 Week Low
- QVCGA $2.27
- ANTX $0.87
- 52 Week High
- QVCGA $39.74
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- ANTX 42.32
- Support Level
- QVCGA N/A
- ANTX $1.05
- Resistance Level
- QVCGA N/A
- ANTX $1.11
- Average True Range (ATR)
- QVCGA 0.00
- ANTX 0.04
- MACD
- QVCGA 0.00
- ANTX 0.00
- Stochastic Oscillator
- QVCGA 0.00
- ANTX 0.00
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.